CAPP-Seq
Circulating Tumor DNA Analysis by CAPP-Seq (Cancer Personalized Profiling by deep Sequencing) is a highly sensitive method for detecting and quantifying cancer-related genetic alterations in the DNA that circulates in the blood. Developed by researchers at Stanford University, CAPP-Seq combines the principles of next-generation sequencing (NGS) with sophisticated bioinformatics to analyze circulating tumor DNA (ctDNA), offering a non-invasive approach for cancer diagnosis, tumor monitoring, and treatment response evaluation.
Overview[edit | edit source]
CAPP-Seq is a revolutionary approach in the field of oncology, enabling the detection of tumor-derived DNA with high sensitivity and specificity. This method involves the sequencing of a panel of cancer-related genes from ctDNA, which is DNA shed from the tumor into the bloodstream. By analyzing these genetic alterations, CAPP-Seq can provide valuable insights into the genetic makeup of a patient's cancer, facilitating personalized treatment strategies.
Methodology[edit | edit source]
The process of CAPP-Seq involves several key steps:
- Sample Collection: Blood samples are collected from the patient, from which plasma is isolated.
- DNA Extraction: ctDNA is extracted from the plasma.
- Library Preparation: The extracted DNA is then prepared into a sequencing library, which involves fragmenting the DNA and attaching adapters for sequencing.
- Target Enrichment: The library is enriched for regions of interest, typically including genes known to be associated with cancer.
- Sequencing: The enriched library is sequenced using next-generation sequencing technology, generating a vast amount of data.
- Data Analysis: Bioinformatics tools are used to analyze the sequencing data, identifying mutations, copy number variations, and other genetic alterations in the ctDNA.
Applications[edit | edit source]
CAPP-Seq has a wide range of applications in oncology, including:
- Early Detection: By detecting ctDNA, CAPP-Seq can identify cancers at an early stage, even before symptoms appear or tumors are detectable by imaging.
- Treatment Monitoring: CAPP-Seq can monitor tumor burden and response to treatment in real-time, allowing for adjustments in therapy based on the genetic evolution of the tumor.
- Resistance Mechanisms: The method can identify genetic mutations that confer resistance to certain therapies, guiding the selection of alternative treatments.
- Minimal Residual Disease: CAPP-Seq can detect minimal residual disease after treatment, predicting relapse before it is clinically apparent.
Advantages[edit | edit source]
CAPP-Seq offers several advantages over traditional methods of cancer detection and monitoring:
- Non-invasive: As a blood-based test, it avoids the need for invasive biopsy procedures.
- High Sensitivity and Specificity: CAPP-Seq can detect ctDNA at very low concentrations, making it highly effective for early detection and monitoring.
- Dynamic Monitoring: It allows for the continuous monitoring of tumor genetics over time, providing insights into tumor evolution and treatment resistance.
Challenges[edit | edit source]
Despite its advantages, CAPP-Seq faces several challenges:
- Cost: The high cost of sequencing and data analysis can limit accessibility.
- Bioinformatics Requirements: The need for sophisticated bioinformatics analysis can be a barrier to widespread implementation.
- Tumor Heterogeneity: The genetic diversity within and between tumors can complicate the interpretation of results.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD